Fermelanta, Inc.

📍 Nonoichi-city, Japan🗓 Founded 2022👥 6 employees💰 Last funded May 2023
Biotechnology Research
LinkedIn
Fermelanta is a Japan-based biotech company that makes beneficial plant-based chemicals by microorganisms. We transform the traditional supply chain depending on agricultural cultivation and extraction into a next-gen microbial fermentation process that can offer low-cost and high-quality products timely. Our cutting-edge technology is introduction and expression techniques and knowhow of unprecedented foreign genes in a cell factory to make microorganisms produce extrinsic metabolites for industrial usage. The target natural molecules are used for health food, cosmetics or approved drugs. Founded in October 2022, we are currently in a lab-based R&D stage and under the first-financing seed round.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Japan
1
Frequently asked questions
Who invested in Fermelanta, Inc.?
Fermelanta, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Fermelanta, Inc. last raise funding?
The most recent investment in Fermelanta, Inc. recorded on gritt.io was in May 2023.
When was Fermelanta, Inc. founded?
Fermelanta, Inc. was founded in 2022.
What industry is Fermelanta, Inc. in?
Fermelanta, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Fermelanta, Inc. based?
Fermelanta, Inc. is headquartered in Nonoichi-city, Japan.